GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Biochar Use in Anaerobic Digestion Found to Enhance Methane Production and Struvite Recovery from Swine Wastewater

by GOAI
Share To

A recent study examines the use of biochar in anaerobic digestion processes to improve the treatment of swine wastewater. The research, titled “Biochar-Assisted Anaerobic Digestion of Swine Wastewater: Feedstock Effects on Methane Production, Nutrient Removal, and Struvite Recovery,” explores how biochar can enhance methane production, facilitate nutrient removal, and support struvite recovery during waste management. Led by researcher A.M. Pat-Espadas and a team of collaborators, the study investigates the potential benefits of integrating biochar into existing waste treatment systems.

The study focuses on the role of biochar as an additive in anaerobic digestion processes. Researchers analyzed its effects on methane yield, which is a key component in renewable energy generation from organic waste. Additionally, they examined how biochar influences nutrient removal efficiency and contributes to struvite recovery—a process that extracts valuable phosphorus-based compounds for agricultural use. The findings aim to provide insights into optimizing sustainable practices for managing swine wastewater while addressing environmental concerns associated with livestock farming operations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top